# Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

> **NCT00003585** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of New Mexico** · enrollment: 35 (estimated)

## Conditions studied

- Kidney Cancer

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** recombinant interferon alfa
- **DRUG:** fluorouracil
- **DRUG:** isotretinoin
- **PROCEDURE:** surgical procedure

## Key facts

- **NCT ID:** NCT00003585
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-08
- **Primary completion:** 2001-08
- **Final completion:** 2002-08
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2013-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003585, "Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00003585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*